Navigation Links
Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
Date:12/9/2008

the acute treatment of agitation in schizophrenic or bipolar disorder patients, has completed both of the planned Phase 3 clinical trials. The Company has completed its end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), which is intended for the acute treatment of migraine headache, and it has advanced AZ-104 (Staccato loxapine) to Phase 2 testing. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. In addition, AZ-002 (Staccato alprazolam) has completed a Phase 2a proof-of-concept clinical trial for the acute treatment of panic attacks -- an indication the Company is not planning to pursue -- and is being assessed for other possible indications and renewed clinical development. More information, including this and past press releases from Alexza, is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development, therapeutic potential, efficacy and safety of AZ-004. Any statement describing a product candidate or Alexza's goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Re
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
2. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
3. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
4. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
5. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
8. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
11. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 ... the appointment of George K. Ng to ... Officer.  In this capacity, Mr. Ng will be responsible ... Mr. Ng joins the Company from BioDelivery Sciences ... General Counsel and a member of senior management that ...
(Date:3/30/2015)... MENLO PARK, Calif. , March 30, 2015 ... company focused on the development of novel drug ... well-defined and underserved markets, today announced the appointment ... executive and retail industry veteran, to its board ... company as it continues to expand its national ...
(Date:3/30/2015)... , March 30, 2015 Alere Inc. (NYSE: ... issued the following statement today in support of President ... Antibiotic-Resistant Bacteria. "As the global leader ... Barack Obama for establishing a National Action ... the serious threat of antibiotic resistance. We look forward ...
Breaking Medicine Technology:Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2
... Pivotal Trial Expected to Initiate in 2010 for BlinatumomabNEW ... MITI ), a biopharmaceutical company developing novel, proprietary antibodies ... today held an R&D Day for investors and financial ... The presentations highlighted significant areas of development across ...
... invivodata inc., the industry leader in ... global clinical research, today announced that it has ... of Chronic pulmonary disease Tool (EXACT) on its ... Outcome (PRO) measure for evaluating the frequency, severity, ...
Cached Medicine Technology:Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4invivodata Certified to Deliver EXACT in COPD Trials 2invivodata Certified to Deliver EXACT in COPD Trials 3
(Date:3/30/2015)... Garden City, NY (PRWEB) March 31, 2015 ... Manager / Co-Founder of Safe Hands Warm Hearts, ... is recognized with this prestigious distinction for leadership in ... women in the country, spanning virtually every industry and ... a powerfully vibrant networking community with nearly 700,000 members ...
(Date:3/30/2015)... This two day PT ... provide medical professionals with the information and techniques ... of fascia and its relationship to proper physiological ... PT CME course will provide extensive ... to identify and treat fascial restrictions. Techniques for ...
(Date:3/30/2015)... Join local United Methodists as they Rethink Church ... to provide healthcare for the 512 students at Raise ... on Saturday, April 18, at 9 a.m. at Edwin ... Road in Nashville. , Raise the Roof Academy in ... medical care. The nearest clinic is a three-hour walk. ...
(Date:3/30/2015)... 30, 2015 Hosted by the ... Cares free, two-day dental clinic in Sacramento provided $2 ... 27-28. , In addition to providing free dental ... barriers to care, CDA Cares educates the public and ... the need for an adequately funded dental safety net, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 The Consumer Attorneys ... Skills for the New Attorneyā€¯ seminar for attorneys who passed ... brings top trial attorneys in the Southern California area to ... Doctors on Liens was on hand, not ... to the doctors their clients will need to help in ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Rachel L. Gregus, Manager / Co-Founder of Safe Hands Warm Hearts, a 2015 Professional Woman of the Year 2Health News:North American Seminars received New Jersey and California approval for Myofascial Release - From Surface to the Depths, a PT and OT Continuing Education Course. 2Health News:Hike2Heal and Rethink Church Raise Funds To Provide Healthcare for Ugandan Children with 3rd Annual Raise the Roof 5K on April 18 2Health News:CDA Cares Sacramento Dental Clinic Provides $2 Million in Care 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 3
... highlights of new cancer research being presented at the ... Annual Meeting on September 21-25, 2008, in Boston. ... releases, contact Beth Bukata at bethb@astro.org or ... until the time of presentation or unless otherwise stated. ...
... High-Caliber Holistic Nutrition Education, NEW YORK, Sept. ... Institute for Integrative Nutrition, has announced an,exciting new ... of,New York (SUNY)., Under the SUNY partnership, ... a certificate upon successful completion of the,Professional Training ...
... Mission to Serve the Needs ... of Patients and Families, ... of the Acting Surgeon General,s Call to Action on venous,thromboembolism (VTE), ... and pulmonary embolism (PE). The,Call to Action urges all Americans to ...
... 100 Salvation Army mobile feeding units are responding,to the ... of,canteens and mobile kitchens are currently in the disaster ... in the areas around Beaumont,Galveston, Houston and Lufkin., ... of this storm and the,extent of the devastation," said ...
... Medifast Cruise 2009, OWINGS MILLS, Md., Sept. 15 ... weight-loss program, today,announced they are challenging dieters and current ... Plan, and then make a brief creative video,to "Express ... to register, challenge rules, and how to upload,videos, can ...
... Five Winner Ali Vincent Featured in New Advertising Campaign ... the first time,contestants on season six of NBC,s wildly ... help from 24 Hour Fitness while,appearing on the show ... reach their,goals at home., Throughout The Biggest Loser: ...
Cached Medicine News:Health News:Groundbreaking cancer studies to be unveiled at ASTRO annual meeting 2Health News:Groundbreaking cancer studies to be unveiled at ASTRO annual meeting 3Health News:Integrative Nutrition Announces Partnership with SUNY 2Health News:Eisai Inc. Supports Acting Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2Health News:Eisai Inc. Supports Acting Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3Health News:Eisai Inc. Supports Acting Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 4Health News:Eisai Inc. Supports Acting Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 5Health News:MultiVu Video Feed: Salvation Army Responding to Hurricane Ike With Food, Water & Pastoral Care 2Health News:Medifast Challenging Dieters to 'Express Your Success' in Video Contest 2Health News:24 Hour Fitness Supports The Biggest Loser for Sixth Consecutive Season 2Health News:24 Hour Fitness Supports The Biggest Loser for Sixth Consecutive Season 3Health News:24 Hour Fitness Supports The Biggest Loser for Sixth Consecutive Season 4
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
... AvantGard Low Binding 20l Barrier Tips. Low ... DNA and proteins bound to the tip. Most ... which means the focus is on liquid not ... focuses on low binding which reduces the binding ...
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
Medicine Products: